← Back to Search

Behavioral Intervention

Gamma-Music Therapy for Alzheimer's Disease (NUGammaMBI Trial)

N/A
Recruiting
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial studies a novel brain-stimulation tool combining gamma-frequency light & music therapy to delay Alzheimer's progression. Results will help develop an adaptive & rewarding protocol to determine who may benefit most.

Who is the study for?
This trial is for individuals aged 55-90 with mild Alzheimer's Disease, confirmed by specific memory and cognitive tests. They must be medically stable, not have a history of substance or alcohol abuse, and be on steady medication for at least three months. A study partner to provide information about the participant is required.
What is being tested?
The trial studies a new brain-stimulation tool that combines gamma-frequency lights with self-selected music (gamma-MBI) to see if it can influence brain activity and delay Alzheimer's progression. It aims to create an enjoyable intervention protocol.
What are the potential side effects?
Since this is a non-invasive intervention using music and light stimulation, side effects are expected to be minimal. However, participants will be monitored for any discomfort or adverse reactions during the sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
EEG activity
Secondary study objectives
ADAS-Cog 14

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: GammaExperimental Treatment1 Intervention
8-week music-based intervention with gamma lights
Group II: ControlPlacebo Group1 Intervention
8-week music-based intervention with control lights

Find a Location

Who is running the clinical trial?

Northeastern UniversityLead Sponsor
98 Previous Clinical Trials
70,936 Total Patients Enrolled

Media Library

Gamma-Music Based Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05984524 — N/A
Alzheimer's Disease Research Study Groups: Gamma, Control
Alzheimer's Disease Clinical Trial 2023: Gamma-Music Based Intervention Highlights & Side Effects. Trial Name: NCT05984524 — N/A
Gamma-Music Based Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05984524 — N/A
~32 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top